Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo. - Wikidata - wikimedia - TriplyDB

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

http://www.wikidata.org/entity/Q34217770

about

Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification Local bacteria affect the efficacy of chemotherapeutic drugs.Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children.The application of physiologically-based pharmacokinetic modelling to assess the impact of antiretroviral-mediated drug-drug interactions on piperaquine antimalarial therapy during pregnancy.Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.CYP2J2 - regulation, function and polymorphism.Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice.Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2

P2860

Q28088352-D3646B15-62DC-4F3B-9E2F-5BB1F4A7AFC3 Q36102269-0E47CAB8-3BFE-4694-B0E8-672FF0EC2FA2 Q36599597-DC2333D2-5085-4CB4-AFC3-475DA2520D23 Q36947747-738A7F38-F431-400F-99F8-13623DC754E3 Q37062630-25F67096-8115-4A74-9791-77FBBF55BDE3 Q40133890-BB57340B-0673-4DF3-AC12-3210DFD638CA Q46249034-226B881E-E6A3-492F-A8E4-41082A80C271 Q51709663-99C531A2-0086-4F44-A3C5-D1F8579C6621 Q54267469-8D490D5A-EC8B-49AC-95BE-AF1D79E937F3 Q57747203-B998206D-34B8-4C52-AAC8-06CCF0551609

P2860

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

http://www.wikidata.org/entity/Q34217770

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@ast

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@en

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@nl

type

label

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@ast

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@en

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@nl

prefLabel

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@ast

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@en

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@nl

P1433

Q34217770-3550A903-D9DC-4E9B-B525-DD1B80D53D91

P1476

Q34217770-34569F4B-A824-4356-ABDF-CD0DE1185CCB

P2093

Q34217770-07DDBFF0-CB16-4826-B232-627D2C2E9E2C

Q34217770-175CC0FF-9826-495C-A1B8-ED67FBD98EF2

Q34217770-4380D4F0-A721-43AF-A85A-FFBDA901E168

Q34217770-6C0F4D6C-BDA8-4AD4-8429-8A2E1E215E4B

Q34217770-83458F04-4458-45A3-88B2-8E94541D52D9

Q34217770-89AD4879-FBCC-4872-AEE3-124C8C5FD8FE

Q34217770-BF80704F-9B79-41B0-8CC8-277FADC72169

P2860

Q34217770-08AD7116-A244-43BD-B836-C323368CA145

Q34217770-0A2B7903-71DC-4FAF-879C-8743E644B967

Q34217770-13E05E5E-ECE7-42B5-961D-915F841E775C

Q34217770-25EC498F-982C-4101-A2E2-CB77B8398B64

Q34217770-26E1F565-00B0-4A76-BFD8-3510FCC74879

Q34217770-31207859-0A7D-4491-8D28-AD40BB0AF373

Q34217770-3C44B4C2-5E63-4561-BA01-BBA427695A26

Q34217770-4771CD06-BD43-4D89-BB05-4DBD6AC5E088

Q34217770-4F586FA5-E30C-41DB-82B0-F9BE4B528ECC

Q34217770-53D64BD8-17E1-4368-A34C-04ABEC38C1BF

P304

Q34217770-E30DD9BA-9AA6-48AD-84E5-21ED96F2BAC6

P31

Q34217770-879E4A57-4863-4C45-99D6-B6B738BC66C9

P356

Q34217770-873DEEA2-9414-4E92-A81D-B63BC0C89165

P407

Q34217770-B0DF4537-EF8C-4E1A-9ABB-51DFD86EF8EE

P433

Q34217770-21430973-E4E5-4C94-9158-C61F36E77CF9

P478

Q34217770-3F80B013-5A27-475C-B5D3-F7C61180EC19

P577

Q34217770-55F94335-8419-4D3B-A6E2-6706872D3D03

P698

Q34217770-8B460DC2-5436-4A19-87E0-D1918F3E6A25

P932

Q34217770-8CCD25C5-1FF2-445C-957B-7656CC988EE8

P356

J.BCP.2014.06.020

P1433

Biochemical Pharmacology

P1476

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo.

@en

P2093

Ann C Collier

http://www.w3.org/2001/XMLSchema#string

Brian J Kirby

http://www.w3.org/2001/XMLSchema#string

Evan D Kharasch

http://www.w3.org/2001/XMLSchema#string

Jashvant D Unadkat

http://www.w3.org/2001/XMLSchema#string

Rheem A Totah

http://www.w3.org/2001/XMLSchema#string

Rüdiger Kaspera

http://www.w3.org/2001/XMLSchema#string

Tariku Sahele

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine

Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole

Effect of fluoxetine on pharmacokinetics of ritonavir.

Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients.

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.

Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: major roles for CYP2J2 and CYP3A.

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

Complex drug interactions of HIV protease inhibitors 1: inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavir

Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects

P304

109-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BCP.2014.06.020

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24973543

http://www.w3.org/2001/XMLSchema#string

P932

4169885

http://www.w3.org/2001/XMLSchema#string